Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  De Castro, Uberdan Guilherme Mendes ^a   Dos Santos, Robson Augusto Souza ^b   Silva, Marcelo Eustáquio ^a   De Lima, Wanderson Geraldo ^a   Campagnole Santos, Maria José ^b   Alzamora, Andréia Carvalho ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

High fat diet; High fructose diet; Metabolic syndrome; NAFLD; Rats of different ages

Indexed keywords

FRUCTOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOCYTE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOMETRY; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; EPIDIDYMIS; GLOMERULOSCLEROSIS; GLYCOGEN LIVER LEVEL; HEART RATE; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; KIDNEY; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; MEAN ARTERIAL PRESSURE; MESENTERY; METABOLIC SYNDROME X; NEPHRITIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITION; RAT; RETROPERITONEUM;

RATTUS;

ADIPOSE TISSUE; AGE FACTORS; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DIET, HIGH-FAT; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; FRUCTOSE; HEART RATE; HUMANS; KIDNEY; LIPID METABOLISM; LIPOPROTEINS; LIVER; MALE; METABOLIC SYNDROME X; RATS; RATS, INBRED F344; TRIGLYCERIDES;

EID: 84884191795     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-136     Document Type: Article

References (66)

1. Banting lecture 1988. Role of insulin resistance in human disease. Reaven GM, Diabetes 1988 37 1595 1607 10.2337/diab.37.12.1595 3056758 (Pubitemid 19004941)
2. Insulin resistance and cardiovascular disease. Ginsberg HN, J Clin Invest 2000 106 453 458 10.1172/JCI10762 10953019 (Pubitemid 30666377)
3. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR, Circulation 2004 110 1245 1250 10.1161/01.CIR.0000140677.20606.0E 15326067 (Pubitemid 39202340)
4. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, Circulation 2004 110 1251 1257 10.1161/01.CIR.0000140762.04598.F9 15326061 (Pubitemid 39202341)
5. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Hanson RL, Imperatore G, Bennett PH, Knowler WC, Diabetes 2002 51 3120 3127 10.2337/diabetes.51.10.3120 12351457
6. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, Diabetes Care 2003 26 3153 3159 10.2337/diacare.26.11.3153 14578254 (Pubitemid 37339513)
7. Obesity: considerations about etiology, metabolism, and the use of experimental models. Pereira-Lancha LO, Campos-Ferraz PL, Lancha AH, Diabetes Metab Syndr Obes 2012 5 75 87 22570558
8. Effect of dietary fat content on total and regional adiposity in men and women. George V, Tremblay A, Després JP, Leblanc C, Bouchard C, Int J Obes 1990 14 1085 1094 2086500
9. Dietary fat and body fat: a multivariate study of 205 adult females. Tucker LA, Kano MJ, Am J Clin Nutr 1992 56 616 622 1414959
10. Diabetes and fructose metabolism. Gerrits PM, Tsalikian E, Am J Clin Nutr 1993 58 796S 799S 8213612 (Pubitemid 23319978)
11. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Häring HU, Fritsche A, Br J Nutr 2011 106 79 86 10.1017/S000711451000574X 21396140
12. Effect of trans-fat, fructose and monosodium glutamate feeding on feline weight gain, adiposity, insulin sensitivity, adipokine and lipid profile. Collison KS, Zaidi MZ, Saleh SM, Inglis A, Mondreal R, Makhoul NJ, Bakheet R, Burrows J, Milgram NW, Al-Mohanna FA, Br J Nutr 2011 106 218 226 10.1017/S000711451000588X 21429276
13. Experimental rat models to study the metabolic syndrome. Aleixandre de Artiñano A, Miguel Castro M, Br J Nutr 2009 102 1246 1253 10.1017/S0007114509990729 19631025
14. Lipid profile and insulin sensitivity in rats fed with high-fat or high-fructose diets. Zaman MQ, Leray V, Le Bloc'h J, Thorin C, Ouguerram K, Nguyen P, Br J Nutr 2011 106 Suppl 1 206 210 22005430
15. Plasma leptin response to oral glucose tolerance and fasting/re-feeding tests in rats with fructose-induced metabolic derangements. Lee YC, Ko YH, Hsu YP, Ho LT, Life Sci 2006 78 1155 1162 10.1016/j.lfs.2005.06.009 16436285 (Pubitemid 43176708)
16. Increasing the fat-to-carbohydrate ratio in a high-fat diet prevents the development of obesity but not a prediabetic state in rats. Sinitskaya N, Gourmelen S, Schuster-Klein C, Guardiola-Lemaitre B, Pévet P, Challet E, Clin Sci (Lond) 2007 113 417 425 10.1042/CS20070182 (Pubitemid 350144376)
17. Opposite lipemic response of Wistar rats and C57BL/6 mice to dietary glucose or fructose supplementation. Barbosa CR, Albuquerque EM, Faria EC, Oliveira HC, Castilho LN, Braz J Med Biol Res 2007 40 323 331 10.1590/S0100-879X2007000300007 17334529 (Pubitemid 46403603)
18. Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress. Matveyenko AV, Gurlo T, Daval M, Butler AE, Butler PC, Diabetes 2009 58 906 916 10.2337/db08-1464 19151199
19. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Buettner R, Schölmerich J, Bollheimer LC, Obesity (Silver Spring) 2007 15 798 808 10.1038/oby.2007.608 (Pubitemid 46740952)
20. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA, Am J Physiol Gastrointest Liver Physiol 2008 295 987 995 10.1152/ajpgi.90272.2008 18772365
21. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. de Moura RF, Ribeiro C, de Oliveira JA, Stevanato E, de Mello MA, Br J Nutr 2009 101 1178 1184 10.1017/S0007114508066774 19007450
22. Components of the AIN-93 diets as improvements in the AIN-76A diet. Reeves PG, J Nutr 1997 127 838S 841S 9164249 (Pubitemid 27209452)
23. Fructose-fed rat hearts are protected against ischemia-reperfusion injury. Joyeux-Faure M, Rossini E, Ribuot C, Faure P, Exp Biol Med (Maywood) 2006 231 456 462
24. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Sánchez-Lozada LG, Tapia E, Jiménez A, Bautista P, Cristóbal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, et al. Am J Physiol Renal Physiol 2007 292 423 429 16940562
25. Sympathetic neural activation in visceral obesity. Alvarez GE, Beske SD, Ballard TP, Davy KP, Circulation 2002 106 2533 2536 10.1161/01.CIR.0000041244. 79165.25 12427647 (Pubitemid 35340687)
26. Reduced parasympathetic control of heart rate in obese dogs. Van Vliet BN, Hall JE, Mizelle HL, Montani JP, Smith MJ, Am J Physiol 1995 269 629 637 7653627
27. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA, Am J Physiol Regul Integr Comp Physiol 2004 287 943 949 10.1152/ajpregu.00265.2004 15191907 (Pubitemid 39280483)
28. Diet, blood pressure and hypertension. Hermansen K, Br J Nutr 2000 83 Suppl 1 113 119 10889801
29. Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension. Verma S, Bhanot S, McNeill JH, Eur J Pharmacol 1999 373 1 4 10.1016/S0014-2999(99)00301-5 10414447 (Pubitemid 29306736)
30. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Catena C, Giacchetti G, Novello M, Colussi G, Cavarape A, Sechi LA, Am J Hypertens 2003 16 973 978 10.1016/S0895-7061(03)01002-1 14573337 (Pubitemid 37315498)
31. Increased functional Na(+)-K+ pump activity in the vasculature of fructose-fed hyperinsulinemic and hypertensive rats. Berger ME, Ormsby BL, Bunnag P, Hori MT, Tuck ML, Golub MS, Hypertens Res 1998 21 73 80 10.1291/hypres.21.73 9661802
32. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Katakam PV, Ujhelyi MR, Hoenig ME, Miller AW, Am J Physiol 1998 275 788 792 9728076
33. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. D'Angelo G, Elmarakby AA, Pollock DM, Stepp DW, Hypertension 2005 46 806 811 10.1161/01.HYP.0000182697.39687.34 16157789 (Pubitemid 43186756)
34. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Wang H, Storlien LH, Huang XF, Am J Physiol Endocrinol Metab 2002 282 1352 1359 12006366
35. A causal role for uric acid in fructose-induced metabolic syndrome. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, et al. Am J Physiol Renal Physiol 2006 290 625 631 16234313
36. Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. Mohamed Salih S, Nallasamy P, Muniyandi P, Periyasami V, Carani Venkatraman A, J Diabetes 2009 1 278 287 10.1111/j.1753-0407.2009.00045.x 20923528
37. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ, J Appl Physiol 2006 100 1467 1474 10.1152/japplphysiol.01438.2005 16357064
38. Dietary leucine improves whole-body insulin sensitivity independent of body fat in diet-induced obese Sprague-Dawley rats. Eller LK, Saha DC, Shearer J, Reimer RA, J Nutr Biochem 2013 24 7 1285 94 10.1016/j.jnutbio.2012.10.004 23332601
39. A mouse model for nonalcoholic steatohepatitis. Sundaresan S, Vijayagopal P, Mills N, Imrhan V, Prasad C, J Nutr Biochem 2011 22 979 984 10.1016/j.jnutbio.2010.08.011 21190824
40. Formation and turnover of triglyceride-rich vesicles in the chick liver cell. Effects of cAMP and carnitine on triglyceride mobilization and conversion to ketones. Mooney RA, Lane MD, J Biol Chem 1981 256 11724 11733 6271759
41. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Huang BW, Chiang MT, Yao HT, Chiang W, Diabetes Obes Metab 2004 6 120 126 10.1111/j.1462-8902.2004.00323.x 14746577 (Pubitemid 38220104)
42. Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice. Jung UJ, Park YB, Kim SR, Choi MS, PLoS One 2012 7 49030 10.1371/journal.pone.0049030 23145054
43. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y, Soejima Y, Fukusato T, World J Gastroenterol 2012 18 2300 2308 10.3748/wjg.v18.i19.2300 22654421
44. Model of nonalcoholic steatohepatitis. Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM, Am J Clin Nutr 2004 79 502 509 14985228 (Pubitemid 41115597)
45. Chronic consumption of a high-fat/high-fructose diet renders the liver incapable of net hepatic glucose uptake. Coate KC, Scott M, Farmer B, Moore MC, Smith M, Roop J, Neal DW, Williams P, Cherrington AD, Am J Physiol Endocrinol Metab 2010 299 887 898 10.1152/ajpendo.00372.2010 20823448
46. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice. Choi S, Choi Y, Kim S, Jang J, Park T, Food Chem 2013 141 3627 3635 10.1016/j.foodchem.2013.06.028 23993530
47. A high-fat, high-fructose diet accelerates nutrient absorption and impairs net hepatic glucose uptake in response to a mixed meal in partially pancreatectomized dogs. Coate KC, Kraft G, Lautz M, Smith M, Neal DW, Cherrington AD, J Nutr 2011 141 1643 1651 10.3945/jn.111.145359 21775526
48. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, Sela BA, Hypertension 2005 45 1012 1018 10.1161/01.HYP.0000164570.20420.67 15824194 (Pubitemid 40628952)
49. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Armutcu F, Coskun O, Gürel A, Kanter M, Can M, Ucar F, Unalacak M, Clin Biochem 2005 38 540 547 10.1016/j.clinbiochem.2005.01.013 15885234 (Pubitemid 40693468)
50. Does fructose consumption contribute to non-alcoholic fatty liver disease? Tappy L, Lê KA, Clin Res Hepatol Gastroenterol 2012 36 554 560 10.1016/j.clinre.2012.06.005 22795319
51. Metabolic effects of fructose and the worldwide increase in obesity. Tappy L, Lê KA, Physiol Rev 2010 90 23 46 10.1152/physrev.00019.2009 20086073
52. Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system. Francini F, Castro MC, Schinella G, García ME, Maiztegui B, Raschia MA, Gagliardino JJ, Massa ML, Life Sci 2010 86 965 971 10.1016/j.lfs.2010.05.005 20470786
53. Liver microsomal glucose-6-phosphatase is competitively inhibited by the lipid products of phosphatidylinositol 3-kinase. Mithieux G, Daniele N, Payrastre B, Zitoun C, J Biol Chem 1998 273 17 19 10.1074/jbc.273.1.17 9417039 (Pubitemid 28042168)
54. Metabolic regulation of fatty acid esterification and effects of conjugated linoleic acid on glucose homeostasis in pig hepatocytes. Conde-Aguilera JA, Lachica M, Nieto R, Fernández-Fígares I, Animal 2012 6 254 261 10.1017/S1751731111001613 22436183
55. The kidney, hypertension, and obesity. Hall JE, Hypertension 2003 41 625 633 10.1161/01.HYP.0000052314.95497.78 12623970 (Pubitemid 36314565)
56. Obesity-associated hypertension and kidney disease. Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam L, Curr Opin Nephrol Hypertens 2003 12 195 200 10.1097/00041552-200303000-00011 12589181 (Pubitemid 36288321)
57. Functional and structural changes in the kidney in the early stages of obesity. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE, J Am Soc Nephrol 2001 12 1211 1217 11373344 (Pubitemid 32472634)
58. Renal hyperfiltration related to diabetes mellitus and obesity in human disease. Sasson AN, Cherney DZ, World J Diabetes 2012 3 1 6 22253940
59. Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet. Palanisamy N, Viswanathan P, Anuradha CV, Ren Fail 2008 30 645 654 10.1080/08860220802134532 18661416
60. Insights into the regulation of renal hemodynamic function in diabetic mellitus. Cherney DZ, Scholey JW, Miller JA, Curr Diabetes Rev 2008 4 280 290 10.2174/157339908786241151 18991597
61. Regulation of the fructose transporter GLUT5 in health and disease. Douard V, Ferraris RP, Am J Physiol Endocrinol Metab 2008 295 227 237 10.1152/ajpendo.90245.2008 18398011
62. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Leturque A, Brot-Laroche E, Le Gall M, Am J Physiol Endocrinol Metab 2009 296 985 992 10.1152/ajpendo.00004.2009 19223655
63. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. Grempler R, Augustin R, Froehner S, Hildebrandt T, Simon E, Mark M, Eickelmann P, FEBS Lett 2012 586 248 253 10.1016/j.febslet.2011.12.027 22212718
64. SGLT5 reabsorbs sructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose. Fukuzawa T, Fukazawa M, Ueda O, Shimada H, Kito A, Kakefuda M, Kawase Y, Wada NA, Goto C, Fukushima N, et al. PLoS One 2013 8 56681 10.1371/journal.pone.0056681 23451068
65. Cardiovascular function in a rat model of diet-induced obesity. Carroll JF, Zenebe WJ, Strange TB, Hypertension 2006 48 65 72 10.1161/01.HYP.0000224147. 01024.77 16702491 (Pubitemid 44297526)
66. High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy. Mellor K, Ritchie RH, Meredith G, Woodman OL, Morris MJ, Delbridge LM, Nutrition 2010 26 842 848 10.1016/j.nut.2009.08.017 19932004 ^UFOP^Universidade Federal de Ouro Preto